EVL
Ena/VASP-like protein
Also known as: EVL_HUMAN, RNB6
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UI08
- Gene
- EVL
- Ensembl
- ENSG00000196405
- Chromosome
- 14
- Canonical length
- 416 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Vesicles,Cytosol
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
Predicted to enable SH3 domain binding activity and profilin binding activity. Involved in negative regulation of epithelial cell migration; negative regulation of ruffle assembly; and positive regulation of stress fiber assembly. Located in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
416 residues, UniProt reviewed canonical sequence.
>Q9UI08|EVL
1 MSEQSICQAR ASVMVYDDTS KKWVPIKPGQ QGFSRINIYH NTASNTFRVV GVKLQDQQVV
61 INYSIVKGLK YNQATPTFHQ WRDARQVYGL NFASKEEATT FSNAMLFALN IMNSQEGGPS
121 SQRQVQNGPS PDEMDIQRRQ VMEQHQQQRQ ESLERRTSAT GPILPPGHPS SAASAPVSCS
181 GPPPPPPPPV PPPPTGATPP PPPPLPAGGA QGSSHDESSM SGLAAAIAGA KLRRVQRPED
241 ASGGSSPSGT SKSDANRASS GGGGGGLMEE MNKLLAKRRK AASQSDKPAE KKEDESQMED
301 PSTSPSPGTR AASQPPNSSE AGRKPWERSN SVEKPVSSIL SRTPSVAKSP EAKSPLQSQP
361 HSRMKPAGSV NDMALDAFDL DRMKQEILEE VVRELHKVKE EIIDAIRQEL SGISTTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against EVL can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.56
- Highest tissue expression
- 223 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 223 nTPM
- retina: 190 nTPM
- basal ganglia: 179 nTPM
- cerebellum: 175 nTPM
- amygdala: 168 nTPM
- thymus: 167 nTPM
Single-cell type
- rod photoreceptor cells: 828 nCPM
- cone photoreceptor cells: 476 nCPM
- t-cells: 473 nCPM
- nk-cells: 433 nCPM
- microglia: 334 nCPM
- thyrotrophs: 299 nCPM
Immune cell
- T-reg: 42 nTPM
- eosinophil: 28 nTPM
- naive CD4 T-cell: 26 nTPM
- naive CD8 T-cell: 25 nTPM
- memory CD4 T-cell: 23 nTPM
- gdT-cell: 20 nTPM
Brain region
- cerebral cortex: 226 nTPM
- basal ganglia: 191 nTPM
- white matter: 169 nTPM
- hypothalamus: 161 nTPM
- amygdala: 161 nTPM
- midbrain: 155 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.24
- gnomAD pLI
- 1
- gnomAD missense Z
- 1.48
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament organization
- actin polymerization or depolymerization
- animal organ morphogenesis
- axon guidance
- cell surface receptor signaling pathway
- negative regulation of epithelial cell migration
- negative regulation of ruffle assembly
- nervous system development
- positive regulation of actin filament polymerization
- positive regulation of stress fiber assembly
- protein homotetramerization
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of EVL in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads EVL as an antibody target. Whether an autoantibody or antibody against EVL could matter depends on whether native EVL is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
EVL is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label EVL as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...